Level – Intermediate

Built Environment + Public Health: Course Curriculum

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: Built Environment + Public Health Curriculum

Type: Online Course

Level: Intermediate

Description: This CDC-funded Web site an interdisciplinary undergraduate, graduate, or continuing education curriculum in public health and built environment. This curriculum is flexible enough to be offered as a full semester course, individual units or single class modules or individual assignments. This Web site also provides opportunity for faculty and other users to share comments, amendments and develop collaborations at the intersection of the built environment and health.



A Model Built Environment and Public Health Course Curriculum: Training for an Interdisciplinary Workforce

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: American Journal of Preventive Medicine

Type: PDF

Level: Intermediate

Discription: Botchwey N, Hobson S, Dannenberg AL, Mumford KG, Contant CK, McMillan TE, Jackson RJ, Lopez R, Winkle C. American Journal of Preventive Medicine. 2009;36(2S):S63–S71.



UC Berkeley Health Impact Group

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: UCBHIG

Type: Online Course

Level: Intermediate

Description: The UC Berkeley Health Impact Group (UCBHIG) is a non-partisan, independent collective whose mission is to promote the field of Health Impact Assessment through advocacy, education, research, and community outreach. UCBHIG’s work focuses largely on the development of qualitative and quantitative tools.



Statistics in Psychosocial Research: Measurement

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: Johns Hopkins Bloomberg School of Public Health

Type: PowerPoint / Lecture Materials

Level: Intermediate

Description: Overview of quantitative approaches to measurement in the psychological and social sciences. Such topics include psychometrics, latent variable analysis, and item response theory.



Health Equity: Progress and Pitfalls

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Souce: University of North Carolina Gillings School of Global Public Health Minority Health Project

Type: Webinar

Level: Intermediate

Discription: Overview of procedures and historical progress



Systematic Review and Meta-Analysis

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: Tufts Clinical and Translational Science Institute

Type: Online Course

Level: Intermediate

Description: “After completing this lecture, you will be able to:
List the reasons for conducting systematic reviews
Appreciate the role of systematic review in CER
Describe the components of a systematic review
State the role of analytic frameworks in systematic review and the approach to formulate answerable systematic review questions
Identify the users and producers of systematic reviews
Define the basic principles of combining data
Identify the common metrics for meta-analysis
List the basics of combining results across studies and effects of weights
Explain the meaning of heterogeneity
Discuss the fixed effect and random effects model
Interpret meta-analysis results”



Retrospective and Observational Comparative Effectiveness Studies

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: Tufts Clinical and Translational Science Institute

Type: Online Course

Level: Intermediate

Description: “After completing this lecture, you will be able to:
State the limitations of randomized controlled trials
Identify the settings in which observational studies of comparative effectiveness may be particularly helpful to clinicians and policymakers
Explain the methodological challenges in conducting retrospective, observational CER using existing sources of data
Describe model-based and other approaches to reduce the effects of confounding in observational CER
Discuss specific examples of retrospective and observational CER, and how these have informed public policy and healthcare delivery system change
List key aspects and the steps of a systematic review
Identify the methodological and inferential challenges of longitudinal observational studies of health outcomes and delivery system change”



Comparative Effectiveness Trials and Assessing Pharmacogenetic Information in Clinical Trials

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: Tufts Clinical and Translational Science Institute

Type: Online Course

Level: Intermediate

Description: “After completing this lecture, you will be able to:
Identify the need for comparative effectiveness trials, even for drug therapies where “”proof of efficacy”" is already required prior to approval
Explain the differences between pragmatic/effectiveness trials and explanatory/efficacy trials
List the strengths and limitations of pragmatic versus explanatory designs
State the strengths and limitations of various types of outcome measures, including surrogate versus clinical outcomes
Explain the difference between prognostic and predictive genetic markers
Identify the pros and cons of alternative research designs for assessing pharmacogenetic (predictive) effects
Discuss “repurposed” randomized trials for assessing pharmacogenetic effects
Define empirical data”



Introduction: A Review of Evidence-Based Medicine (EBM) and a Framework for Understanding the CER Agenda

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: Tufts Clinical and Translational Science Institute

Type: Online Course

Level: Intermediate

Description: “After completing this lecture, you will be able to: List the principles of Evidence-Based Medicine (EBM), state how CER extends the principles of EBM, describe a framework for understanding the CER agenda, and identify the stakeholders of CER”.



Comparative Effectiveness Research: Recent History, Role in Healthcare Reform and Rationale for CER

VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Source: Tufts Clinical and Translational Science Institute

Type: Online Course

Level: Intermediate

Description: “After completing this lecture, you will be able to:
Define CER based on standard definitions and the typical activities that it encompasses
Review the motivations, accomplishments, and impediments for CER
Describe how CER is supported in the United States now and how the new Patient-Centered Outcomes Research Institute will support CER
Identify the roles for CTSAs in facilitating and implementing CER
Discuss specific needs, next steps, and the future of CER
Identify the forces shaping national priorities for CER in the United States
Explain the current CER landscape in the United States
Compare and contrast comparative effectiveness and cost-effectiveness research”